Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of Inhaled BIIX 1 XX in Healthy Males
NCT02198313Phase 1Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 1999
- Primary completion
- Apr 1999
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of olodaterol in Respiratory Disease (RD) (4 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Number of subjects with adverse events, Number of subjects with abnormal changes in laboratory parameters and 2 more. Started Apr 1999; status: terminated.
02
Drugs
olodaterol
03
Conditions
Respiratory Disease (RD)
Beyond the preview
Go deeper on NCT02198313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02198313.